PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

Logo of diaMary Ann Liebert, Inc.Mary Ann Liebert, Inc.JournalsSearchAlerts
Diabetes Technology & Therapeutics
 

Table 1.

Patient Characteristics

Demographic (n=28)
Race
 African American1 (3.5%)
 White26 (91%)
 Hispanic1 (3.5%)
Age
 Young children (4–7 years)14 (50%)
 Adolescents (12–17 years)14 (50%)
Gender
 Male19 (67.9%)
 Female9 (32.1%)
Weight (kg)40.64 (22.63)
Duration of type 1 diabetes (years)5.16 (3.00)
Total daily insulin dose (units/kg)0.79 (0.22)
Glycemic variables
 HbA1c (%)7.69 (0.79)
 Time in hypoglycemia (<70 mg/dL) 72 h prior to induced hypoglycemia (min)138.21 (208.71)
 CONGA (mg/dL)46.3 (17.55)
 HBGI32.59 (9.49)
 LBGI5.95 (5.57)
Baseline CR hormones
 Glucagon (pg/mL)43.73 (11.91)
 Cortisol (μg/dL)11.16 (3.22)
 Growth hormone (ng/mL)4.42 (6.16)
 Epinephrine (pg/mL)41.50 (17.81)
 Norepinephrine (pg/mL)142.43 (49.90)

Data are number (%) or mean (SD) values as indicated.

CONGA, continuous overall net glycemic action; CR, counterregulatory; HbA1c, hemoglobin A1c; HBGI, High Blood Glucose Index; LBGI, Low Blood Glucose Index.